. J. Nat. Prod. 2014, 77, 2651?2657. [18] Cheng, Z.B.; Deng, Y.L.; Fan, C.Q.; Han, Q.H.; Lin, S.L.; Tang, G.H.; Luo, H.-B.*; Yin, S.* Prostaglandin Derivatives: Nonaromatic Phosphodiesterase-4 Inhibitors from the Soft Coral Sarcophyton ehrenbergi. J. Nat. Prod. 2014, 77, 1928–1936. PMID: 25075977[19] Lin, T.T.; Huang, Y.Y.; Tang, G.H.; Cheng, Z.B.; Liu, X.; Luo, H.-B.*; Yin, S.* Prenylated Coumarins: Natural Phosphodiesterase-4 Inhibitors from Toddalia asiatica. J. Nat. Prod. 2014, 77: 955-962. PMID:24597921[20] Liu, Y.N.; Huang, Y.Y.; Bao, J.M.; Cai, Y.H.; Guo, Y.Q.; Liu, S.N.; Luo, H.-B.*; Yin, S.* Natural phosphodiesterase-4 (PDE4) inhibitors from Crotalaria Ferruginea. Fitoterapi 2014, 94: 177-182. PMID:24594242[21] Huang, Y.Y.; Li, Z.; Cai, Y.H.; Feng, L.J.; Wu, Y.; Li, X.; Luo, H.-B.* The molecular basis for the selectivity of tadalafil toward phosphodiesterase 5 and 6: A modeling study. J. Chem. Inf. Model. 2013, 53, 3044-3053. PMID: 24180640.[22] Li, Z.; Cai, Y.H.; Cheng, Y.K.; Lu, X.; Shao, Y.X.; Li, X.; Liu, M.; Liu, P.; Luo, H.-B.* Identification of novel phosphodiesterase-4D inhibitors prescreened by molecular dynamics-augmented modeling and validated by bioassay. J. Chem. Inf. Model. 2013,53, 972-981.PMID: 23517293.[23] Zhao, P.; Chen, S.K.; Cai, Y.H.; Lu, X.; Li, Z.; Cheng, Y.K.; Zhang, C.; Hu, X.; He, X.*; Luo, H.-B.* The molecular basis for the inhibition of phosphodiesterase-4D by three natural resveratrol analogs. Isolation, molecular docking, molecular dynamics simulations, binding free energy, and bioassay. Biochim Biophys Acta. 2013, 1834(10): 2089-2096. PMID: 23871879. [24] Zhong, J.; Huang, Y.; Ding, W.; Wu, X.; Wan, J.*; Luo, H.-B.* Chemical constituents of Aloe barbadensis Miller and their inhibitory effects on phosphodiesterase-4D. Fitoterapia. 2013, 91:159-165. PMID: 24028970.[25] Li, Y.P.; Weng, X.; Ning, F.X.; Ou, J.B.; Hou, J.Q.; Luo, H.-B.*; Li, D.; Huang, Z.S.; Huang, S.L.*; Gu, L.Q. 3D-QSAR studies of azaoxoisoaporphine, oxoaporphine, and oxoisoaporphine derivatives as anti-AChE and anti-AD agents by the CoMFA method. J. Mol. Graph. Model. 2013, 41: 61-67. PMID: 23500628.[26] Meng, F.; Hou, J.; Shao, Y. X.; Wu, P. Y.; Huang, M.; Zhu, X.; Cai, Y. H.; Li, Z.; Xu, J.; Liu, P. Q.; Luo, H.-B.*; Wan, Y.*; Ke, H*. Structure-based discovery of highly selective phosphodiesterase-9A inhibitors and implications for inhibitor design. J. Med. Chem. 2012, 55(19): 8549-8558. PMID: 22985069.[27] Park, S.J.; Ahmad, F.; Philp, A.; Baar, K.; Williams, T.; Luo, H.B.; Ke, H.M.; Rehmann, H.; Taussig, R.; Brown, A.L.; Kim, M.K.; Beaven, M.A.; Burgin, A.B.; Manganiello, V.; Chung, J.H. Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell 2012, 148(3): 421-433. PMID: 22304913.[28] Chen, S.-K.; Zhao, P.; Shao, Y.-X.; Li, Z.; Liu, M.; Zhang, C.X.; Liu, P.Q.; He, X.X.*; Luo, H.-B.*; Hu, X.P. Moracin M from Morus alba L. is a natural phosphodiesterase-4 inhibitor. Bioorg. Med. Chem. Lett. 2012, 22: 3261–3264. PMID:22483586 [29] Zheng, X.H.; Shao, Y.X.; Li, Z.; Liu, M.; Bu, X.Z.; Luo, H.-B.*; Hu, X.P. Quantitative structure-retention relationship of curcumin and its analogues. J. Sep. Sci. 2012, 35: 505-512. PMID:22282411[30] Shao, Y.X; Zhao, P.; Li, Z.; Liu, M.; Liu, P.Q.; Huang, M.; Luo, H.-B.* The molecular basis for the inhibition of human cytochrome P450 1A2 by oroxylin and wogonin. Eur. Biophys. J. 2012, 41: 297-306.[31] Zheng, X.H.; Zhang, L.P.; Zhai, J; Chen, Y.Y.; Luo, H.-B.*; Hu, X.P.* The molecular basis for inhibition of sulindac and its metabolites towards human aldose reductase. FEBS Lett. 2012, 586: 55-59. PMID:22228220[32] Fang, J.; Huang, D.; Zhao, W.; Ge, H.;Luo, H.-B.*; Xu, J.* A new protocol for predicting novel GSK-3 beta ATP competitive inhibitors. J. Chem. Inf. Model. 2011, 51: 1431-1438.[33] Hou, J.; Xu, J.; Liu, M.; Zhao, R.; Luo, H.-B.*; Ke, H.* Structural asymmetry of phosphodiesterase-9, potential protonation of a glutamic acid, and role of the invariant glutamine.